Chlamydia Trachomatis Immunology and Vaccinology Study
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The primary objective is to prospectively follow 200 women with or at risk of cervicitis to
determine the chlamydia-specific cellular responses that correlate with protection against
incident infection. The hypothesis is that a positive IFN-y response by peripheral CD4+ T
cells responding to stimulation with HSP60 will be significantly associated with protection
from incident C. trachomatis infection.
Details
Lead Sponsor:
Harold Wiesenfeld
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)